Latin American Developing Markets for Pharmaceuticals, 2006-2011

Released on = April 30, 2007, 9:10 pm

Press Release Author = Bharat Book Bureau

Industry = Pharmaceuticals

Press Release Summary = The purpose of Developing Markets Series is to examine the
prospects for the growth of pharmaceutical revenues in the developing economies of
Asia, Latin America and Eastern/Central Europe.

Press Release Body = Latin American Developing Markets for Pharmaceuticals,
2006-2011 discusses prospects for the large developing market of Latin America.
Importantly, the growth of pharmaceutical markets in Latin America has the potential
to offset serious problems currently being experienced by your industry. The purpose
of this visiongain report is to examine the prospects for the growth of
pharmaceutical revenues in the developing economies of Latin America, at both
regional and national level.

The growth of pharmaceutical markets in Latin America nations has the potential to
offset serious problems currently experienced by the global industry. The principal
challenge is slow growth in North America, Western Europe and Japan.
In contrast, visiongain predicts that all the leading developing markets will
exhibit strong growth from 2006-2011. Rapid economic growth and large, under-served
populations will drive that expansion. There will be significant growth in sales of
both branded and generic drugs through increasing demand from both public and
private healthcare sectors.

- Will counterfeit drugs impact on these opportunities? Find out in this exclusive
management report.

Latin American Developing Markets for Pharmaceuticals, 2006-2011, examines
developing pharmaceutical markets critically through comprehensive research and
analysis. Visiongain applied techniques such as financial forecasting, SWOT analyses
and discussion of qualitative factors. Societal, political, economic and commercial
issues are covered. The result is a comprehensive market-based report with detailed
analysis and informed opinion.

In particular, Latin American Developing Markets for Pharmaceuticals, 2006-2011,
concentrates on the following themes :

A forecast of the global pharmaceutical market from 2006-2011, with key issues
discussed
Forecasts of sales revenues and growth rates for leading developing markets in Latin
America from 2006-2011
Drivers and opportunities in those markets
Restraints and threats in those markets
Discussion of key players and important therapeutic areas
Discussion of relevant regulatory, societal and economic issues
Comparison of the prospects for revenue generation in Asia, Latin America and
Central/Eastern Europe, with overall forecasts for those regions
7 Reasons



Why you should buy this report :

To receive a comprehensive analysis of the prospects for developing regional and
national markets for pharmaceuticals in Latin America from 2006-2011, as well as
comparative data for other developing regions
To discover predicted revenues, growth rates and other key metrics for Latin
American developing markets from 2006-2011
To determine the forces that influence pharmaceutical sales in the Latin American
developing markets
Secure Competitive advantage win the market, both at national and regional level
To benefit from the Regulatory, technological, societal and political opportunities
in Latin America
Understand the critical Drivers and restraints to success in Latin America
Harness the Strengths, weaknesses, opportunities and threats your company faces
through investment in Latin America
The dominant pharmaceutical markets of North America, Western Europe and Japan
currently account for approximately 85% of revenues for prescription drugs. However,
there is concern about the relatively low growth of those established markets in
recent years. Consequently, companies like yours are very interested in raising
their profiles in the developing market of Latin America. Give your company that
extra edge by discovering the opportunities today.

Growth of the pharmaceutical markets in developing nations will clearly surpass that
of the established markets. That situation will provide one of the greatest
opportunities currently available to the international pharmaceutical industry. Many
developing countries have strongly growing economies; that factor constitutes a
driving force in the reform and broadening of healthcare systems. Improvements in
both the quality and reach of these healthcare provisions will drive the sales of
branded and generic products. Private healthcare will undergo similar developments.

Manufacturers of pharmaceuticals are currently working hard to address unmet
healthcare needs in developing countries. By doing so, they are making better
treatments available to millions of patients and improving the overall performance
of their companies.

You cannot afford to ignore this expanding market. A small investment today will be
the catalyst of a great return for your company tomorrow.

Unique benefits to you when you order this report



- Immediate access through our exclusive Reading Room
- You can access your report whichever country you are in without using hard drive
space
- Primary research throughout. You will not find this information anywhere else
- Report stored in your reading room for ever
- Copies can be printed off for offline reading
- Packed with charts, analysis, figures, graphs and tables

If you buy one report this year make sure it is the report that will guarantee your
success for the next few years. Order this report now.

For more information, Please visit : http://www.bharatbook.com/detail.asp?id

Web Site = http://www.bharatbook.com

Contact Details = Bharat Book Bureau
207, Hermes Atrium,Navi Mumbai 400 614. India
Ph. : +91-(022)-2757 8668 or Fax +91-(022)-2757 9131
Email : bharatbook@gmail.com, Web : www.bharatbook.com

  • Printer Friendly Format
  • Back to previous page...
  • Back to home page...
  • Submit your press releases...
  •